Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro.

Random sequence mutagenesis in conjunction with genetic complementation was used to map the function of amino acid residues within the putative nucleoside binding site of the herpes simplex virus type 1 (HSV-1) thymidine kinase (TK). Six codons of the putative nucleoside binding site of the HSV-1 tk were substituted by a duplex of extended oligonucleotides containing 20% random sequences. Approximately 260 mutants were screened for the ability to genetically complement a TK-deficient Escherichia coli. Of those screened, 32% conferred TK activity. Approximately 60% of the TK positive clones contained single amino acid changes, 23% contained double changes, and 13.4% encoded the wild-type TK amino acid sequence. A small percentage of clones, 2.4% and 1.2%, contained triple or quadruple alterations, respectively. Three residues (D162, H163, and R164) appeared to be highly conserved especially with regard to the type of residues able to substitute. Secondary screening results indicated that several of the mutants had higher affinities for acyclovir and/or 3'-azido-3'-deoxythymidine than thymidine in complementation assays. In addition, a number of clones were unable to form colonies on selection medium at elevated temperatures (42 degrees C). Eight selected mutants were subcloned into an in vitro transcription vector and the derived transcripts used to program a rabbit reticulocyte lysate cell-free translation system. Biologically active translation products were then analyzed in vitro for thymidine kinase activity, for thermal stability, and for the ability to phosphorylate selected nucleoside analogues. Two of the eight mutants had an elevated thymidine kinase activity, two were significantly thermolabile, and three exhibited enhanced efficiency in phosphorylation of nucleoside analogues.

[1]  Z. Ram,et al.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.

[2]  M. Black,et al.  A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase. , 1992, The Journal of biological chemistry.

[3]  L. Loeb,et al.  Permissible amino acid substitutions within the putative nucleoside binding site of herpes simplex virus type 1 encoded thymidine kinase established by random sequence mutagenesis [corrected]. , 1992, The Journal of biological chemistry.

[4]  M. Gruidl,et al.  Mapping and molecular characterization of a functional thymidine kinase from Amsacta moorei entomopoxvirus. , 1992, Virology.

[5]  L. Loeb,et al.  Artificial mutants generated by the insertion of random oligonucleotides into the putative nucleoside binding site of the HSV-1 thymidine kinase gene. , 1991, Biochemistry.

[6]  G. Folkers,et al.  Conformational and epitope mapping of herpes-simplex-virus type-1 thymidine kinase using synthetic peptide segments. , 1991, European journal of biochemistry.

[7]  G. Gentry,et al.  Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. , 1990, The Journal of general virology.

[8]  M. Black,et al.  Identification of the ATP-binding domain of vaccinia virus thymidine kinase. , 1990, The Journal of biological chemistry.

[9]  A. Griffin,et al.  Analysis of the nucleotide sequence of DNA from the region of the thymidine kinase gene of infectious laryngotracheitis virus; potential evolutionary relationships between the herpesvirus subfamilies. , 1990, The Journal of general virology.

[10]  S. Scott,et al.  Nucleotide and predicted amino acid sequences of the Marek's disease virus and turkey herpesvirus thymidine kinase genes; comparison with thymidine kinase genes of other herpesviruses. , 1989, The Journal of general virology.

[11]  L. Williams,et al.  A comparative analysis of the sequence of the thymidine kinase gene of a gammaherpesvirus, herpesvirus saimiri. , 1989, The Journal of general virology.

[12]  J. Nunberg,et al.  Identification of the thymidine kinase gene of feline herpesvirus: use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologs , 1989, Journal of virology.

[13]  S. Martin,et al.  Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys , 1989, Journal of virology.

[14]  M. Black,et al.  Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase. , 1989, Gene.

[15]  H. Field,et al.  Analysis of the bovine herpesvirus type 1 thymidine kinase (TK) gene from wild-type virus and TK-deficient mutants. , 1989, The Journal of general virology.

[16]  J. Arrand,et al.  Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems , 1988, Journal of virology.

[17]  M. Sawyer,et al.  Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. , 1988, The Journal of general virology.

[18]  T. Steitz,et al.  Purification and crystallization of thymidine kinase from herpes simplex virus type 1. , 1988, Journal of molecular biology.

[19]  A J Davison,et al.  The complete DNA sequence of varicella-zoster virus. , 1986, The Journal of general virology.

[20]  B. Larder,et al.  Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. , 1986, The Journal of general virology.

[21]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[22]  H. Otsuka,et al.  Nucleotide sequence of the marmoset herpesvirus thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide. , 1984, Virology.

[23]  G. Milman,et al.  Purification and characterization of herpes simplex virus (type 1) thymidine kinase produced in Escherichia coli by a high efficiency expression plasmid utilizing a lambda PL promoter and cI857 temperature-sensitive repressor. , 1983, The Journal of biological chemistry.

[24]  D. Galloway,et al.  Nucleotide sequence of the herpes simplex virus type 2 thymidine kinase gene , 1983, Journal of virology.

[25]  L. A. Ball,et al.  Cell-free synthesis of enzymatically active vaccinia virus thymidine kinase. , 1981, Virology.

[26]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Igarashi,et al.  A deoxythymidine kinase deficient mutant of Escherichia coli. II. Mapping and transduction studies with phage phi 80. , 1967, Genetics.